The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.

Canadian journal of neuroscience nursing

Volumn 34, Issue 3, 2012, Pages 7-11

  Fox, Robert ^a  

^a BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; HUMAN; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL (TOPIC);

ADMINISTRATION, ORAL; CLINICAL TRIALS, PHASE III AS TOPIC; FUMARATES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS;

EID: 84874523713     PISSN: 19137176     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)